544 related articles for article (PubMed ID: 10911802)
21. Correlation of seven biological factors (Hsp90a, p53, MDM2, Bcl-2, Bax, Cytochrome C, and Cleaved caspase3) with clinical outcomes of ALK+ anaplastic large-cell lymphoma.
Li HL; Huang XP; Zhou XH; Ji TH; Wu ZQ; Wang ZQ; Jiang HY; Liu FR; Zhao T
Biomed Environ Sci; 2011 Dec; 24(6):630-41. PubMed ID: 22365399
[TBL] [Abstract][Full Text] [Related]
22. Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomas.
Ott G; Katzenberger T; Siebert R; DeCoteau JF; Fletcher JA; Knoll JH; Kalla J; Rosenwald A; Ott MM; Weber-Matthiesen K; Kadin ME; Müller-Hermelink HK
Genes Chromosomes Cancer; 1998 Jun; 22(2):114-21. PubMed ID: 9598798
[TBL] [Abstract][Full Text] [Related]
23. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
Stein H; Foss HD; Dürkop H; Marafioti T; Delsol G; Pulford K; Pileri S; Falini B
Blood; 2000 Dec; 96(12):3681-95. PubMed ID: 11090048
[TBL] [Abstract][Full Text] [Related]
24. ALCL by any other name: the many facets of anaplastic large cell lymphoma.
Irshaid L; Xu ML
Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671
[TBL] [Abstract][Full Text] [Related]
25. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
Savage KJ; Harris NL; Vose JM; Ullrich F; Jaffe ES; Connors JM; Rimsza L; Pileri SA; Chhanabhai M; Gascoyne RD; Armitage JO; Weisenburger DD;
Blood; 2008 Jun; 111(12):5496-504. PubMed ID: 18385450
[TBL] [Abstract][Full Text] [Related]
26. Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature.
Miranda RN; Lin L; Talwalkar SS; Manning JT; Medeiros LJ
Arch Pathol Lab Med; 2009 Sep; 133(9):1383-90. PubMed ID: 19722744
[TBL] [Abstract][Full Text] [Related]
27. Recurrent ALK-negative anaplastic large T-cell lymphoma presenting as necrotizing vasculitis.
Nambudiri VE; Aboutalebi A; Granter SR; Saavedra A
Am J Dermatopathol; 2013 Jun; 35(4):512-6. PubMed ID: 23291583
[TBL] [Abstract][Full Text] [Related]
28. Anaplastic large cell lymphoma, ALK-negative.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow involvement in NPM-ALK-positive lymphoma: report of two cases.
Sadahira Y; Hata S; Sugihara T; Manabe T
Pathol Res Pract; 1999; 195(9):657-61. PubMed ID: 10507087
[TBL] [Abstract][Full Text] [Related]
30. Primary gastrointestinal anaplastic large cell lymphoma.
Lee YY; Takata K; Wang RC; Yang SF; Chuang SS
Pathology; 2017 Aug; 49(5):479-485. PubMed ID: 28693749
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype.
Suzuki R; Kagami Y; Takeuchi K; Kami M; Okamoto M; Ichinohasama R; Mori N; Kojima M; Yoshino T; Yamabe H; Shiota M; Mori S; Ogura M; Hamajima N; Seto M; Suchi T; Morishima Y; Nakamura S
Blood; 2000 Nov; 96(9):2993-3000. PubMed ID: 11049976
[TBL] [Abstract][Full Text] [Related]
32. ALK-positive anaplastic large-cell lymphoma with primary bone involvement: A rare case and review of the literature.
Noh BJ; Han CS; Park JS; Lee J; Kim YW; Park YK
Malays J Pathol; 2018 Aug; 40(2):161-167. PubMed ID: 30173234
[TBL] [Abstract][Full Text] [Related]
33. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.
Eyre TA; Khan D; Hall GW; Collins GP
Eur J Haematol; 2014 Dec; 93(6):455-68. PubMed ID: 24766435
[TBL] [Abstract][Full Text] [Related]
34. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
[TBL] [Abstract][Full Text] [Related]
35. How to Diagnose Anaplastic Large Cell Lymphoma on Cytological Samples? A Series with Emphasis on Diagnostic Clue and Pitfalls.
Montella M; Lucà S; Ronchi A; Marino FZ; Caputo A; Sica A; Zeppa P; Franco R; Cozzolino I
Acta Cytol; 2023; 67(3):230-239. PubMed ID: 36634640
[TBL] [Abstract][Full Text] [Related]
36. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
[TBL] [Abstract][Full Text] [Related]
37. Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma.
Kutok JL; Aster JC
J Clin Oncol; 2002 Sep; 20(17):3691-702. PubMed ID: 12202671
[TBL] [Abstract][Full Text] [Related]
38. Systemic, primary cutaneous, and breast implant-associated ALK-negative anaplastic large-cell lymphomas present similar biologic features despite distinct clinical behavior.
Gerbe A; Alame M; Dereure O; Gonzalez S; Durand L; Tempier A; De Oliveira L; Tourneret A; Costes-Martineau V; Cacheux V; Szablewski V
Virchows Arch; 2019 Aug; 475(2):163-174. PubMed ID: 30953147
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma.
Liu C; Iqbal J; Teruya-Feldstein J; Shen Y; Dabrowska MJ; Dybkaer K; Lim MS; Piva R; Barreca A; Pellegrino E; Spaccarotella E; Lachel CM; Kucuk C; Jiang CS; Hu X; Bhagavathi S; Greiner TC; Weisenburger DD; Aoun P; Perkins SL; McKeithan TW; Inghirami G; Chan WC
Blood; 2013 Sep; 122(12):2083-92. PubMed ID: 23801630
[TBL] [Abstract][Full Text] [Related]
40. The heterogeneous landscape of ALK negative ALCL.
Mereu E; Pellegrino E; Scarfò I; Inghirami G; Piva R
Oncotarget; 2017 Mar; 8(11):18525-18536. PubMed ID: 28061468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]